These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 17602576)
21. Formulation and evaluation of novel reverse microemulsions containing salmon calcitonin in hydrofluoroalkane propellants. Shan Z; Tan Y; Qin L; Li G; Pan X; Wang Z; Yu X; Wang Q; Wu C Int J Pharm; 2014 May; 466(1-2):390-9. PubMed ID: 24657140 [TBL] [Abstract][Full Text] [Related]
22. High-pressure aerosol suspensions--a novel laser diffraction particle sizing system for hydrofluoroalkane pressurised metered dose inhalers. Jones SA; Martin GP; Brown MB Int J Pharm; 2005 Sep; 302(1-2):154-65. PubMed ID: 16102928 [TBL] [Abstract][Full Text] [Related]
23. A Review of Methods for Evaluating Particle Stability in Suspension Based Pressurized Metered Dose Inhalers. D'Sa D; Chan HK Curr Pharm Des; 2015; 21(27):3955-65. PubMed ID: 26290200 [TBL] [Abstract][Full Text] [Related]
24. A randomized, double-blind, double-dummy, single-dose, crossover trial evaluating the efficacy and safety profiles of two dose levels (12 and 24 microg) of formoterol-HFA (pMDI) vs. those of a dose level (24 microg) of formoterol-DPI (Foradil/Aerolizer) and of placebo (pMDI or Aerolizer) in moderate to severe asthmatic patients. Bousquet J; Guenolé E; Duvauchelle T; Vicaut E; Lefrançois G Respiration; 2005; 72 Suppl 1():13-9. PubMed ID: 15915008 [TBL] [Abstract][Full Text] [Related]
25. Crosslinked chitosan nanoparticle formulations for delivery from pressurized metered dose inhalers. Sharma K; Somavarapu S; Colombani A; Govind N; Taylor KM Eur J Pharm Biopharm; 2012 May; 81(1):74-81. PubMed ID: 22245573 [TBL] [Abstract][Full Text] [Related]
26. Core-shell particles for the dispersion of small polar drugs and biomolecules in hydrofluoroalkane propellants. Wu L; Bharatwaj B; Panyam J; da Rocha SR Pharm Res; 2008 Feb; 25(2):289-301. PubMed ID: 17943419 [TBL] [Abstract][Full Text] [Related]
27. The processing of nanoparticles containing protein for suspension in hydrofluoroalkane propellants. Nyambura BK; Kellaway IW; Taylor KM Int J Pharm; 2009 May; 372(1-2):140-6. PubMed ID: 19429273 [TBL] [Abstract][Full Text] [Related]
28. Insulin nanoparticles: stability and aerosolization from pressurized metered dose inhalers. Nyambura BK; Kellaway IW; Taylor KM Int J Pharm; 2009 Jun; 375(1-2):114-22. PubMed ID: 19481697 [TBL] [Abstract][Full Text] [Related]
29. The CFC to HFA transition and its impact on pulmonary drug development. Leach CL Respir Care; 2005 Sep; 50(9):1201-8. PubMed ID: 16122403 [TBL] [Abstract][Full Text] [Related]
30. Double-blind, double-dummy, multinational, multicenter, parallel-group design clinical trial of clinical non-inferiority of formoterol 12 microg/unit dose in a b.i.d. regimen administered via an HFA-propellant-pMDI or a dry powder inhaler in a 12-week treatment period of moderate to severe stable persistent asthma in adult patients. Dusser D; Vicaut E; Lefrançois G; Respiration; 2005; 72 Suppl 1():20-7. PubMed ID: 15915009 [TBL] [Abstract][Full Text] [Related]
31. Isothermal microcalorimetry of pressurized systems I: a rapid method to evaluate pressurized metered dose inhaler formulations. D'Sa DJ; Lechuga-Ballesteros D; Chan HK Pharm Res; 2014 Oct; 31(10):2716-23. PubMed ID: 24760449 [TBL] [Abstract][Full Text] [Related]
32. Metered dose inhalers in the transition to low GWP propellants: what we know and what is missing to make it happen. Buttini F; Glieca S; Sonvico F; Lewis DA Expert Opin Drug Deliv; 2023; 20(8):1131-1143. PubMed ID: 37767756 [TBL] [Abstract][Full Text] [Related]
33. Predicting physical stability in pressurized metered dose inhalers via dwell and instantaneous force colloidal probe microscopy. D'Sa D; Chan HK; Chrzanowski W Eur J Pharm Biopharm; 2014 Sep; 88(1):129-35. PubMed ID: 25058596 [TBL] [Abstract][Full Text] [Related]
38. Computational analyses of a pressurized metered dose inhaler and a new drug-aerosol targeting methodology. Kleinstreuer C; Shi H; Zhang Z J Aerosol Med; 2007; 20(3):294-309. PubMed ID: 17894536 [TBL] [Abstract][Full Text] [Related]
39. Solubility of solid solutes in HFA-134a with a correlation to physico-chemical properties. Hoye JA; Gupta A; Myrdal PB J Pharm Sci; 2008 Jan; 97(1):198-208. PubMed ID: 17828733 [TBL] [Abstract][Full Text] [Related]
40. Surfactant design for the 1,1,1,2-tetrafluoroethane-water interface: ab initio calculations and in situ high-pressure tensiometry. Selvam P; Peguin RP; Chokshi U; da Rocha SR Langmuir; 2006 Oct; 22(21):8675-83. PubMed ID: 17014104 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]